Controversial oncoologist-haematologist Vinay Prasad will be the FDA's top vaccine regulator. Apart from his extensive research and contribution in the field of oncology, he is known for his scathing remarks against the FDA and US health policies.
FDA Commissioner Martin Makary announced Prasad’s appointment as the new director of the Center for Biologics Evaluation and Research, which oversees review of vaccines, blood products and some genetic medicines.
“Dr Prasad brings the kind of scientific rigor, independence, and transparency we need at CBER—a significant step forward,” Makary wrote in a post on the social media site X.
In recent years, Prasad has become a regular on podcasts associated with Health Secretary Kennedy’s “Make America Healthy Again” movement.
Prasad's criticism of US health policies
During the pandemic, Dr Prasad found fault with social distancing and expressed doubt over vaccine for children. He also criticized Donald Trump during the pandemic for taking disproven medicines to prevent the spread of the virus and for refusing to use facemasks at the White House.
He freely expresses his opinion in X, his Substack called Sensible Medicine and the podcast The Plenary Session. He is the author of the books "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer" and "Ending Medical Reversal: Improving Outcomes, Saving Lives."
Who is Vinay Prasad? His early life
Born in the US to immigrant parents, Dr Prasad's early life was in Ohio and Chicago. He went to Michigan State University, where he took courses in health care ethics and physiology. He completed his medical degree at the University of Chicago in 2009 and completed a residency in internal medicine at Northwestern University in 2012. From 2015 to 2020, Prasad was assistant and then associate professor at the Oregon Health & Science University. He currently works at San Francisco General Hospital. Prasad is currently a full professor of hematology-oncology at UCSF.
FDA Commissioner Martin Makary announced Prasad’s appointment as the new director of the Center for Biologics Evaluation and Research, which oversees review of vaccines, blood products and some genetic medicines.
“Dr Prasad brings the kind of scientific rigor, independence, and transparency we need at CBER—a significant step forward,” Makary wrote in a post on the social media site X.
I’m proud to welcome Dr. Vinay Prasad, MD, MPH, as the new head of FDA’s Center for Biologics Evaluation & Research. With 500+ peer-reviewed publications and two books, Dr. Prasad brings the kind of scientific rigor, independence, and transparency we need at CBER—a significant…
— Dr. Martin Makary (@DrMakaryFDA) May 6, 2025
In recent years, Prasad has become a regular on podcasts associated with Health Secretary Kennedy’s “Make America Healthy Again” movement.
Prasad's criticism of US health policies
During the pandemic, Dr Prasad found fault with social distancing and expressed doubt over vaccine for children. He also criticized Donald Trump during the pandemic for taking disproven medicines to prevent the spread of the virus and for refusing to use facemasks at the White House.
He freely expresses his opinion in X, his Substack called Sensible Medicine and the podcast The Plenary Session. He is the author of the books "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer" and "Ending Medical Reversal: Improving Outcomes, Saving Lives."
Who is Vinay Prasad? His early life
Born in the US to immigrant parents, Dr Prasad's early life was in Ohio and Chicago. He went to Michigan State University, where he took courses in health care ethics and physiology. He completed his medical degree at the University of Chicago in 2009 and completed a residency in internal medicine at Northwestern University in 2012. From 2015 to 2020, Prasad was assistant and then associate professor at the Oregon Health & Science University. He currently works at San Francisco General Hospital. Prasad is currently a full professor of hematology-oncology at UCSF.
You may also like
'Focused, measured and non-escalatory in nature': Government on 'Operation Sindoor' in Pakistan in Pahalgam attack aftermath
India fires missiles at Pakistan and disputed Kashmir region as WW3 fears grow
Paige Bueckers feared major wardrobe malfunction at worst time in WNBA Draft
India launches missile strikes on Pakistan as Kashmir rocked by explosions
Pahalgam terror attack: Army launches Operation Sindoor; justice is served, says Indian Army
